Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression*
- K. Kim, Jae-Joon Song, J. An, Y. Kwon, Yong J. Lee
- Biology, ChemistryJournal of Biological Chemistry
- 9 December 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be selective in the induction of apoptosis in cancer cells with minimal toxicity to normal tissues and studies suggested that ASA-promoted TRAIL cytotoxicity is mediated through down-regulating BCL-2 and by decreasing mitochondrial membrane potential.
In-vitro anticancer activity of green synthesized silver nanoparticles on MCF-7 human breast cancer cells.
Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress.
Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.
Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor.
Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway
The present studies suggest that amiloride enhances TRAIL-induced cytotoxicity by inhibiting phosphorylation of the PI3K-Akt pathway-associated kinases and phosphatases.
Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation
A novel paradigm whereby post-translational modification induces apoptotic cell death in breast cancer cells resistant to standard chemotherapeutic agents through secretion of auto- or paracrine molecules such as Ac-APE1/Ref-1 is introduced.
The hexane fraction of Naematoloma sublateritium extract suppresses the TNF-α-induced metastatic potential of MDA-MB-231 breast cancer cells through modulation of the JNK and p38 pathways.
- Yu Ran Lee, K. Kim, B. Jeon, Sunga Choi
- Biology, MedicineInternational Journal of Oncology
- 1 September 2014
HFNS inhibits the metastatic potential of MDA-MB‑231 cells by inhibiting the phosphorylation of JNK/p38 and reducing AP-1 and NFκB DNA-binding activities, suggesting that HFNS may be a potential therapeutic agent against metastasis of breast cancer.
Role of HER‐2/neu signaling in sensitivity to tumor necrosis factor‐related apoptosis‐inducing ligand: Enhancement of TRAIL‐mediated apoptosis by amiloride
It is suggested that amiloride enhances TRAIL‐induced cytotoxicity by inhibiting phosphorylation of the HER‐2/neu‐PI3K‐Akt pathway‐associated kinases and phosphatase.
Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo
The stimulation of apoptosis by the binding of secreted acetylated-apurinic apyrimidinic endonuclease 1/redox factor-1 to the receptor for advanced glycation end products (RAGE) was essential for TNBC cell death in response to hyperacetylation.